VAERS reports by lot

Moderna COVID-19 lot 003K21-2A: VAERS reports

210 VAERS reports list lot 003K21-2A as a Moderna COVID-19 vaccine, received between 2022-01-25 and 2023-02-24. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
210
Reports
5%
Marked serious
1
With a death outcome
13
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
General / Systemic (non-local)4424%
Neurological2614%
Cardiac / Cardiovascular2111%
Injection-site / Local reaction2011%
Musculoskeletal169%
Gastrointestinal158%
Allergic / Anaphylactic137%
Respiratory137%
Dermatological (non-injection-site)137%
Psychiatric / Neuropsychiatric63%

Where reports came from

U.S. state of the reporter, where given (top 12).

Puerto Rico80
Colorado68
New York7
Washington4
Illinois4
Minnesota4
Tennessee4
California4
Michigan4
Oregon3
New Mexico3
Pennsylvania3

Reports by month received

2022-016
2022-0215
2022-0320
2022-0413
2022-052
2022-0665
2022-076
2022-089
2022-0969
2022-101
2022-111
2023-011
2023-022

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.